Patents by Inventor Jean Harb

Jean Harb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers for the Diagnosis of Renal Allograft and Kidney Status
    Publication number: 20120046181
    Abstract: The present invention relates to the identification and use of protein biomarkers with clinical relevance to kidney status and chronic renal injury or disorder. In particular, the invention provides the identity of marker proteins which are recognized by antibodies present in patients suffering from end-stage renal disorder, stable renal transplant, renal transplant glomerulopathy (TG), and interstitial fibrosis and tubular atrophy (IFTA). Methods and kits are described for using these proteins in the study and diagnosis of chronic renal transplant injury, and in the selection and/or monitoring of treatment regimens.
    Type: Application
    Filed: December 17, 2009
    Publication date: February 23, 2012
    Applicants: CHU NANTES, INSERM (Institut National de la Sante et de la Recherche Medicale), UNIVERSITE DE NANTES
    Inventors: Jean Harb, Maryvonne Hourmant, Sandrine Le Roux
  • TRUNCATED BARD1 PROTEIN, AND ITS DIAGNOSTIC AND THERAPEUTIC USES
    Publication number: 20100016228
    Abstract: The invention concerns a novel polypeptide derived from the cleavage of the BARD1 protein, a nucleic acid encoding for said polypeptide, and their diagnostic and therapeutic uses, in particular for treating tumors.
    Type: Application
    Filed: June 23, 2009
    Publication date: January 21, 2010
    Applicant: Ayanda Biosystems SA
    Inventors: FABIEN GAUTIER, Jean Harb, Khaled Meflah, Irmgard Irminger-Finger
  • Truncated BARD1 protein, and its diagnostic and therapeutic uses
    Patent number: 7566764
    Abstract: The invention concerns a novel polypeptide derived from the cleavage of the BARD1 protein, a nucleic acid coding for said polypeptide, and their diagnostic and therapeutic uses, in particular for treating tumours.
    Type: Grant
    Filed: September 3, 2001
    Date of Patent: July 28, 2009
    Assignee: Ayanda Biosystems SA
    Inventors: Fabien Gautier, Jean Harb, Khaled Meflah, Irmgard Irminger-Finger
  • Truncated bard1 protein, and its diagnostic and therapeutic uses
    Publication number: 20040234959
    Abstract: The invention concerns a novel polypeptide derived from the cleavage of the BARD1 protein, a nucleic acid coding for said polypeptide, and their diagnostic and therapeutic uses, in particular for treating tumours.
    Type: Application
    Filed: May 22, 2003
    Publication date: November 25, 2004
    Inventors: Fabien Gautier, Jean Harb, Khaled Meflah, Irmgard Irminger-Finger